II
iBio, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$26Msold at filing
Total offering$26M
Investors in the raise7count reported to the SEC
FiledJan 22, 2026first sale Jan 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David A. ArkowitzDirector
William A. ClarkDirector
Martin A. BrennerExecutive Officer, Director
Antonio A. ParadaDirector
Marc A. BanjakExecutive Officer
Evert A. ShimmelpenninkDirector
Felipe A. DuranExecutive Officer
Alexandra A. KropotovaDirector
Gary A. SenderDirector
Executive officers, directors and promoters as listed on the Form D.